Cardiovascular Disease In Patients Treated For Multiple Sclerosis: A Study Using The Us Department Of Defense Database

被引：0
|
作者：
Persson, R. [1 ]
Yood, M. Ulcickas [2 ,3 ]
Wagner, M. [4 ]
Evans, A. [5 ]
Lee, S. [6 ]
Minton, N. [6 ]
Niemcryk, S. [6 ]
Lindholm, A. [6 ]
Jick, S. [1 ,2 ]
机构：
[1] Boston Collaborat Drug Surveillance Program, Lexington, MA USA
[2] Boston Univ, Sch Publ Hlth, Boston, MA USA
[3] EpiSource, Newton, MA USA
[4] Naval Med Ctr Portsmouth, Portsmouth, VA USA
[5] Hlth ResearchTx LLC, Trevose, PA USA
[6] Celgene Corp, Summit, NJ USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 1_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P082
引用
收藏
页码：54 / 54
页数：1
相关论文
共 50 条
  • [21] Rate of cardiovascular disease among Swedish multiple sclerosis patients treated with rituximab, natalizumab, fingolimod, and dimethyl fumarate: a nationwide cohort study
    Frisell, T.
    Cuijpers, M.
    Piehl, F.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 314 - 314
  • [22] Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2020 Updated US Department of Veterans Affairs and US Department of Defense Clinical Practice Guideline
    O'Malley, Patrick G.
    Arnold, Michael J.
    Kelley, Cathy
    Spacek, Lance
    Buelt, Andrew
    Natarajan, Sundar
    Donahue, Mark P.
    Vagichev, Elena
    Ballard-Hernandez, Jennifer
    Logan, Amanda
    Thomas, Lauren
    Ritter, Joan
    Neubauer, Brian E.
    Downs, John R.
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (10) : 822 - +
  • [23] Clinical outcomes of patients with multiple sclerosis treated with ocrelizumab in a US community MS center: an observational study
    Smoot, Kyle
    Chen, Chiayi
    Stuchiner, Tamela
    Lucas, Lindsay
    Grote, Lois
    Cohan, Stanley
    BMJ NEUROLOGY OPEN, 2021, 3 (02)
  • [24] Magical ideation - Defense mechanism or neuropathology? A study with multiple sclerosis patients
    Wildta, BTT
    Schultz-Venrath, U
    PSYCHOPATHOLOGY, 2004, 37 (03) : 141 - 144
  • [25] Burden of illness in multiple sclerosis (DEFENSE) study: the costs and quality-of-life of Finnish patients with multiple sclerosis
    Ruutiainen, Juhani
    Viita, Anna-Mari
    Hahl, Jarmo
    Sundell, Jesse
    Nissinen, Helena
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (01) : 21 - 33
  • [26] Infectious Disease Surveillance in the US Department of Defense European Region
    Steele, J. A.
    Allen, K.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 53 : 119 - 119
  • [27] Age-and Gender-Specific Incidence of Malignant Neoplasms in Patients with Multiple Sclerosis Using a US Claims Database
    Gandhi, Sampada K.
    Kumar, Meera
    Juhaeri, Juhaeri
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 74 - 74
  • [28] Infections in patients diagnosed with multiple sclerosis: A multi-database study
    Persson, R.
    Lee, S.
    Yood, M. Ulcickas
    Wagner, C. A. P. T. M.
    Minton, N.
    Niemcryk, S.
    Lindholm, A.
    Evans, A. M.
    Jick, S. S.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 41
  • [29] Comorbidity in US patients with multiple sclerosis
    Edwards, Natalie C.
    Munsell, Michael
    Menzin, Joseph
    Phillips, Amy L.
    PATIENT-RELATED OUTCOME MEASURES, 2018, 9 : 97 - 102
  • [30] Epidemiology of paediatric multiple sclerosis as observed in a US claims database
    Gungabissoon, U.
    Morris, D.
    Juneja, M.
    Weil, J.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S39 - S39
12345